Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

  • 1,935 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • …
  • 177
  • 178
  • 179
  • …
  • 193
  • 194
  • Next →
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Sander Kersten, Josiane Seydoux, Jeffrey M. Peters, Frank J. Gonzalez, Béatrice Desvergne, Walter Wahli
Sander Kersten, Josiane Seydoux, Jeffrey M. Peters, Frank J. Gonzalez, Béatrice Desvergne, Walter Wahli
View: Text | PDF

Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

  • Text
  • PDF
Abstract

Prolonged deprivation of food induces dramatic changes in mammalian metabolism, including the release of large amounts of fatty acids from the adipose tissue, followed by their oxidation in the liver. The nuclear receptor known as peroxisome proliferator–activated receptor α (PPARα) was found to play a role in regulating mitochondrial and peroxisomal fatty acid oxidation, suggesting that PPARα may be involved in the transcriptional response to fasting. To investigate this possibility, PPARα-null mice were subjected to a high fat diet or to fasting, and their responses were compared with those of wild-type mice. PPARα-null mice chronically fed a high fat diet showed a massive accumulation of lipid in their livers. A similar phenotype was noted in PPARα-null mice fasted for 24 hours, who also displayed severe hypoglycemia, hypoketonemia, hypothermia, and elevated plasma free fatty acid levels, indicating a dramatic inhibition of fatty acid uptake and oxidation. It is shown that to accommodate the increased requirement for hepatic fatty acid oxidation, PPARα mRNA is induced during fasting in wild-type mice. The data indicate that PPARα plays a pivotal role in the management of energy stores during fasting. By modulating gene expression, PPARα stimulates hepatic fatty acid oxidation to supply substrates that can be metabolized by other tissues.

Authors

Sander Kersten, Josiane Seydoux, Jeffrey M. Peters, Frank J. Gonzalez, Béatrice Desvergne, Walter Wahli

×

A novel role for cardiac neural crest in heart development
Karen Waldo, Marzena Zdanowicz, Jarrett Burch, Donna H. Kumiski, Harriet A. Stadt, Robert E. Godt, Tony L. Creazzo, Margaret L. Kirby
Karen Waldo, Marzena Zdanowicz, Jarrett Burch, Donna H. Kumiski, Harriet A. Stadt, Robert E. Godt, Tony L. Creazzo, Margaret L. Kirby
View: Text | PDF

A novel role for cardiac neural crest in heart development

  • Text
  • PDF
Abstract

Ablation of premigratory cardiac neural crest results in defective development of the cardiac outflow tract. The purpose of the present study was to correlate the earliest functional and morphological changes in heart development after cardiac neural crest ablation. Within 24 hours after neural crest ablation, the external morphology of the hearts showed straight outflow limbs, tighter heart loops, and variable dilations. Incorporation of bromodeoxyuridine in myocytes, an indication of proliferation, was doubled after cardiac neural crest ablation. The myocardial calcium transients, which are a measure of excitation-contraction coupling, were depressed by 50% in both the inflow and outflow portions of the looped heart tube. The myocardial transients could be rescued by replacing the cardiac neural crest. The cardiac jelly produced by the myocardium was distributed in an uneven, rather than uniform, pattern. An extreme variability in external morphology could be attributed to the uneven distribution of cardiac jelly. In the absence of cardiac neural crest, the myocardium was characterized by somewhat disorganized myofibrils that may be a result of abnormally elevated proliferation. In contrast, endocardial development appeared normal, as evidenced by normal expression of fibrillin-2 protein (JB3 antigen) and normal formation of cushion mesenchyme and trabeculae. The signs of abnormal myocardial development coincident with normal endocardium suggest that the presence of cardiac neural crest cells is necessary for normal differentiation and function of the myocardium during early heart development. These results indicate a novel role for neural crest cells in myocardial maturation.

Authors

Karen Waldo, Marzena Zdanowicz, Jarrett Burch, Donna H. Kumiski, Harriet A. Stadt, Robert E. Godt, Tony L. Creazzo, Margaret L. Kirby

×

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension
Mark W. Geraci, Bifeng Gao, David C. Shepherd, Mark D. Moore, Jay Y. Westcott, Karen A. Fagan, Lori A. Alger, Rubin M. Tuder, Norbert F. Voelkel
Mark W. Geraci, Bifeng Gao, David C. Shepherd, Mark D. Moore, Jay Y. Westcott, Karen A. Fagan, Lori A. Alger, Rubin M. Tuder, Norbert F. Voelkel
View: Text | PDF

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension

  • Text
  • PDF
Abstract

Prostacyclin synthase (PGIS) is the final committed enzyme in the metabolic pathway leading to prostacyclin (PGI2) production. Patients with severe pulmonary hypertension have a PGIS deficiency of their precapillary vessels, but the importance of this deficiency for lung vascular remodeling remains unclear. We hypothesized that selective pulmonary overexpression of PGIS may prevent the development of pulmonary hypertension. To study this hypothesis, transgenic mice were created with selective pulmonary PGIS overexpression using a construct of the 3.7-kb human surfactant protein-C (SP-C) promoter and the rat PGIS cDNA. Transgenic mice (Tg+) and nontransgenic littermates (Tg–) were subjected to a simulated altitude of 17,000 ft for 5 weeks, and right ventricular systolic pressure (RVSP) was measured. Histology was performed on the lungs. The Tg+ mice produced 2-fold more pulmonary 6-keto prostaglandin F1α (PGF1α) levels than did Tg– mice. After exposure to chronic hypobaric hypoxia, Tg+ mice have lower RVSP than do Tg– mice. Histologic examination of the lungs revealed nearly normal arteriolar vessels in the Tg+ mice in comparison with vessel wall hypertrophy in the Tg– mice. These studies demonstrate that Tg+ mice were protected from the development of pulmonary hypertension after exposure to chronic hypobaric hypoxia. We conclude that PGIS plays a major role in modifying the pulmonary vascular response to chronic hypoxia. This has important implications for the pathogenesis and treatment of severe pulmonary hypertension.

Authors

Mark W. Geraci, Bifeng Gao, David C. Shepherd, Mark D. Moore, Jay Y. Westcott, Karen A. Fagan, Lori A. Alger, Rubin M. Tuder, Norbert F. Voelkel

×

Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions
Farid J. Ghadessy, Joyce Lim, Abdullah A.R. Abdullah, Valerie Panet-Raymond, Chee Keong Choo, Rose Lumbroso, Thein G. Tut, Bruce Gottlieb, Leonard Pinsky, Mark A. Trifiro, Eu Leong Yong
Farid J. Ghadessy, Joyce Lim, Abdullah A.R. Abdullah, Valerie Panet-Raymond, Chee Keong Choo, Rose Lumbroso, Thein G. Tut, Bruce Gottlieb, Leonard Pinsky, Mark A. Trifiro, Eu Leong Yong
View: Text | PDF

Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions

  • Text
  • PDF
Abstract

Structural changes in the androgen receptor (AR) are one of the causes of defective spermatogenesis. We screened the AR gene of 173 infertile men with impaired spermatogenesis and identified 3 of them, unrelated, who each had a single adenine→guanine transition that changed codon 886 in exon 8 from methionine to valine. This mutation was significantly associated with the severely oligospermic phenotype and was not detected in 400 control AR alleles. Despite the location of this substitution in the ligand-binding domain (LBD) of the AR, neither the genital skin fibroblasts of the subjects nor transfected cell types expressing the mutant receptor had any androgen-binding abnormality. However, the mutant receptor had a consistently (approximately 50%) reduced capacity to transactivate each of 2 different androgen-inducible reporter genes in 3 different cell lines. Deficient transactivation correlated with reduced binding of mutant AR complexes to androgen response elements. Coexpression of AR domain fragments in mammalian and yeast two-hybrid studies suggests that the mutation disrupts interactions of the LBD with another LBD, with the NH2-terminal transactivation domain, and with the transcriptional intermediary factor TIF2. These data suggest that a functional element centered around M886 has a role, not for ligand binding, but for interdomain and coactivator interactions culminating in the formation of a normal transcription complex.

Authors

Farid J. Ghadessy, Joyce Lim, Abdullah A.R. Abdullah, Valerie Panet-Raymond, Chee Keong Choo, Rose Lumbroso, Thein G. Tut, Bruce Gottlieb, Leonard Pinsky, Mark A. Trifiro, Eu Leong Yong

×

Mild spherocytosis and altered red cell ion transport in protein 4.2–null mice
Luanne L. Peters, Hitesh K. Jindel, Babette Gwynn, Cathy Korsgren, Kathryn M. John, Samuel E. Lux, Narla Mohandas, Carl M. Cohen, Michael R. Cho, David E. Golan, Carlo Brugnara
Luanne L. Peters, Hitesh K. Jindel, Babette Gwynn, Cathy Korsgren, Kathryn M. John, Samuel E. Lux, Narla Mohandas, Carl M. Cohen, Michael R. Cho, David E. Golan, Carlo Brugnara
View: Text | PDF

Mild spherocytosis and altered red cell ion transport in protein 4.2–null mice

  • Text
  • PDF
Abstract

Protein 4.2 is a major component of the red blood cell (RBC) membrane skeleton. We used targeted mutagenesis in embryonic stem (ES) cells to elucidate protein 4.2 functions in vivo. Protein 4.2–null (4.2–/–) mice have mild hereditary spherocytosis (HS). Scanning electron microscopy and ektacytometry confirm loss of membrane surface in 4.2–/– RBCs. The membrane skeleton architecture is intact, and the spectrin and ankyrin content of 4.2–/– RBCs are normal. Band 3 and band 3–mediated anion transport are decreased. Protein 4.2–/– RBCs show altered cation content (increased K+/decreased Na+)resulting in dehydration. The passive Na+ permeability and the activities of the Na-K-2Cl and K-Cl cotransporters, the Na/H exchanger, and the Gardos channel in 4.2–/– RBCs are significantly increased. Protein 4.2–/– RBCs demonstrate an abnormal regulation of cation transport by cell volume. Cell shrinkage induces a greater activation of Na/H exchange and Na-K-2Cl cotransport in 4.2–/– RBCs compared with controls. The increased passive Na+ permeability of 4.2–/– RBCs is also dependent on cell shrinkage. We conclude that protein 4.2 is important in the maintenance of normal surface area in RBCs and for normal RBC cation transport.

Authors

Luanne L. Peters, Hitesh K. Jindel, Babette Gwynn, Cathy Korsgren, Kathryn M. John, Samuel E. Lux, Narla Mohandas, Carl M. Cohen, Michael R. Cho, David E. Golan, Carlo Brugnara

×

Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
Stephen L. Tilley, Laurent P. Audoly, Elizabeth H. Hicks, Hyung-Suk Kim, Patrick J. Flannery, Thomas M. Coffman, Beverly H. Koller
Stephen L. Tilley, Laurent P. Audoly, Elizabeth H. Hicks, Hyung-Suk Kim, Patrick J. Flannery, Thomas M. Coffman, Beverly H. Koller
View: Text | PDF

Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor

  • Text
  • PDF
Abstract

Prostaglandins (PGs) are bioactive lipids that modulate a broad spectrum of biologic processes including reproduction and circulatory homeostasis. Although reproductive functions of mammals are influenced by PGs at numerous levels, including ovulation, fertilization, implantation, and decidualization, it is not clear which PGs are involved and whether a single mechanism affects all reproductive functions. Using mice deficient in 1 of 4 prostaglandin E2 (PGE2) receptors — specifically, the EP2 receptor — we show that Ep2–/– females are infertile secondary to failure of the released ovum to become fertilized in vivo. Ep2–/– ova could be fertilized in vitro, suggesting that in addition to previously defined roles, PGs may contribute to the microenvironment in which fertilization takes place. In addition to its effects on reproduction, PGE2 regulates regional blood flow in various vascular beds. However, its role in systemic blood pressure homeostasis is not clear. Mice deficient in the EP2 PGE2 receptor displayed resting systolic blood pressure that was significantly lower than in wild-type controls. Blood pressure increased in these animals when they were placed on a high-salt diet, suggesting that the EP2 receptor may be involved in sodium handling by the kidney. These studies demonstrate that PGE2, acting through the EP2 receptor, exerts potent regulatory effects on two major physiologic processes: blood pressure homeostasis and in vivo fertilization of the ovum.

Authors

Stephen L. Tilley, Laurent P. Audoly, Elizabeth H. Hicks, Hyung-Suk Kim, Patrick J. Flannery, Thomas M. Coffman, Beverly H. Koller

×

Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Eugene A. Podrez, David Schmitt, Henry F. Hoff, Stanley L. Hazen
Eugene A. Podrez, David Schmitt, Henry F. Hoff, Stanley L. Hazen
View: Text | PDF

Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro

  • Text
  • PDF
Abstract

Oxidized LDL is implicated in atherosclerosis; however, the pathways that convert LDL into an atherogenic form in vivo are not established. Production of reactive nitrogen species may be one important pathway, since LDL recovered from human atherosclerotic aorta is enriched in nitrotyrosine. We now report that reactive nitrogen species generated by the MPO-H2O2-NO2– system of monocytes convert LDL into a form (NO2-LDL) that is avidly taken up and degraded by macrophages, leading to massive cholesterol deposition and foam cell formation, essential steps in lesion development. Incubation of LDL with isolated MPO, an H2O2-generating system, and nitrite (NO2–)— a major end-product of NO metabolism—resulted in nitration of apolipoprotein B 100 tyrosyl residues and initiation of LDL lipid peroxidation. The time course of LDL protein nitration and lipid peroxidation paralleled the acquisition of high-affinity, concentration-dependent, and saturable binding of NO2-LDL to human monocyte–derived macrophages and mouse peritoneal macrophages. LDL modification and conversion into a high-uptake form occurred in the absence of free metal ions, required NO2–, occurred at physiological levels of Cl–, and was inhibited by heme poisons, catalase, and BHT. Macrophage binding of NO2-LDL was specific and mediated by neither the LDL receptor nor the scavenger receptor class A type I. Exposure of macrophages to NO2-LDL promoted cholesteryl ester synthesis, intracellular cholesterol and cholesteryl ester accumulation, and foam cell formation. Collectively, these results identify MPO-generated reactive nitrogen species as a physiologically plausible pathway for converting LDL into an atherogenic form.

Authors

Eugene A. Podrez, David Schmitt, Henry F. Hoff, Stanley L. Hazen

×

The IL-1 receptor and Rho directly associate to drive cell activation in inflammation
R. Singh, B. Wang, A. Shirvaikar, S. Khan, S. Kamat, J.R. Schelling, M. Konieczkowski, J.R. Sedor
R. Singh, B. Wang, A. Shirvaikar, S. Khan, S. Kamat, J.R. Schelling, M. Konieczkowski, J.R. Sedor
View: Text | PDF

The IL-1 receptor and Rho directly associate to drive cell activation in inflammation

  • Text
  • PDF
Abstract

IL-1–stimulated mesenchymal cells model molecular mechanisms of inflammation. Binding of IL-1 to the type I IL-1 receptor (IL-1R) clusters a multi-subunit signaling complex at focal adhesion complexes. Since Rho family GTPases coordinately organize actin cytoskeleton and signaling to regulate cell phenotype, we hypothesized that the IL-1R signaling complex contained these G proteins. IL-1 stimulated actin stress fiber formation in serum-starved HeLa cells in a Rho-dependent manner and rapidly activated nucleotide exchange on RhoA. Glutathione S-transferase (GST) fusion proteins, containing either the full-length IL-1R cytosolic domain (GST-IL-1Rcd) or the terminal 68 amino acids of IL-1R required for IL-1–dependent signal transduction, specifically coprecipitated both RhoA and Rac-1, but not p21ras, from Triton-soluble HeLa cell extracts. In whole cells, a small-molecular-weight G protein coimmunoprecipitated by anti–IL-1R antibody was a substrate for C3 transferase, which specifically ADP-ribosylates Rho GTPases. Constitutively activated RhoA, loaded with [γ-32P]GTP, directly interacted with GST-IL-1Rcd in a filter-binding assay. The IL-1Rcd-RhoA interaction was functionally important, since a dominant inhibitory mutant of RhoA prevented IL-1Rcd–directed transcriptional activation of the IL-6 gene. Consistent with our previous data demonstrating that IL-1R–associated myelin basic protein (MBP) kinases are necessary for IL-1–directed gene expression, cellular incorporation of C3 transferase inhibited IL-1R–associated MBP kinase activity both in solution and in gel kinase assays. In summary, IL-1 activated RhoA, which was physically associated with IL-1Rcd and necessary for activation of cytosolic nuclear signaling pathways. These findings suggest that IL-1–stimulated, Rho-dependent cytoskeletal reorganization may cluster signaling molecules in specific architectures that are necessary for persistent cell activation in chronic inflammatory disease.

Authors

R. Singh, B. Wang, A. Shirvaikar, S. Khan, S. Kamat, J.R. Schelling, M. Konieczkowski, J.R. Sedor

×

The immunoglobulin-like modules Cε3 and α2 are the minimal units necessary for human IgE-FcεRI interaction
Luca Vangelista, Sylvia Laffer, Robert Turek, Hans Grönlund, Wolfgang R. Sperr, Peter Valent, Annalisa Pastore, Rudolf Valenta
Luca Vangelista, Sylvia Laffer, Robert Turek, Hans Grönlund, Wolfgang R. Sperr, Peter Valent, Annalisa Pastore, Rudolf Valenta
View: Text | PDF

The immunoglobulin-like modules Cε3 and α2 are the minimal units necessary for human IgE-FcεRI interaction

  • Text
  • PDF
Abstract

Atopic allergy is a genetically determined immunodisorder that affects almost 20% of the population worldwide. Immediate symptoms of type I allergy are caused by the release of biologic mediators from effector cells induced by IgE-allergen complexes that cross-link the high-affinity receptor for IgE (FcεRI). Chronic disease manifestations result from allergen-specific T-cell activation, a process that is enhanced when allergens are presented via FcεRI-bound IgE. We report the baculovirus expression, as soluble recombinant proteins, of the minimal units required for human IgE and FcεRI interaction: Cε3 represents the third constant domain of the IgE heavy chain, and α2 is the membrane-proximal Ig-like module from FcεRIα. Native overlay experiments showed binding of human FcεRIα to recombinant Cε3 and of natural or recombinant human IgE to recombinant α2. Moreover, recombinant Cε3 inhibited binding of natural IgE antibodies to α2, and preincubation of human IgE with α2 inhibited anti-IgE–triggered histamine release from human basophils. Isolated Cε3 and α2 can now be used for the molecular and structural analysis of the IgE-FcεRI interaction, as well as for diagnostic and therapeutic applications.

Authors

Luca Vangelista, Sylvia Laffer, Robert Turek, Hans Grönlund, Wolfgang R. Sperr, Peter Valent, Annalisa Pastore, Rudolf Valenta

×

Apo E structure determines VLDL clearance and atherosclerosis risk in mice
Christopher Knouff, Myron E. Hinsdale, Hafid Mezdour, Michael K. Altenburg, Masahiko Watanabe, Steven H. Quarfordt, Patrick M. Sullivan, Nobuyo Maeda
Christopher Knouff, Myron E. Hinsdale, Hafid Mezdour, Michael K. Altenburg, Masahiko Watanabe, Steven H. Quarfordt, Patrick M. Sullivan, Nobuyo Maeda
View: Text | PDF

Apo E structure determines VLDL clearance and atherosclerosis risk in mice

  • Text
  • PDF
Abstract

We have generated mice expressing the human apo E4 isoform in place of the endogenous murine apo E protein and have compared them with mice expressing the human apo E3 isoform. Plasma lipid and apolipoprotein levels in the mice expressing only the apo E4 isoform (4/4) did not differ significantly from those in mice with the apo E3 isoform (3/3) on chow and were equally elevated in response to increased lipid and cholesterol in their diet. However, on all diets tested, the 4/4 mice had approximately twice the amount of cholesterol, apo E, and apo B-48 in their VLDL as did 3/3 mice. The 4/4 VLDL competed with human LDL for binding to the human LDL receptor slightly better than 3/3 VLDL, but the VLDL clearance rate in 4/4 mice was half that in 3/3 mice. On an atherogenic diet, there was a trend toward greater atherosclerotic plaque size in 4/4 mice compared with 3/3 mice. These data, together with our earlier observations in wild-type and human APOE*2-replacement mice, demonstrate a direct and highly significant correlation between VLDL clearance rate and mean atherosclerotic plaque size. Therefore, differences solely in apo E protein structure are sufficient to cause alterations in VLDL residence time and atherosclerosis risk in mice.

Authors

Christopher Knouff, Myron E. Hinsdale, Hafid Mezdour, Michael K. Altenburg, Masahiko Watanabe, Steven H. Quarfordt, Patrick M. Sullivan, Nobuyo Maeda

×
  • ← Previous
  • 1
  • 2
  • …
  • 177
  • 178
  • 179
  • …
  • 193
  • 194
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts